Showing 1 - 20 results of 41 for search '"attention-deficit hyperactivity disorder"', query time: 0.13s Refine Results
  1. 1
  2. 2
  3. 3

    Prevalence of Undiagnosed Attention Deficit Hyperactivity Disorder by Carissa Du, Daniel Zongliang Zhao, Latha Ganti

    Published 2025-01-01
    “…# Background Attention deficit/hyperactivity disorder (ADHD) is a disorder characterized by inattention, hyperactivity, and impulsivity. …”
    Get full text
    Article
  4. 4

    Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder by Christopher L Robinson, Katelyn Parker, Saurabh Kataria, Evan Downs, Rajesh Supra, Alan D. Kaye, Omar Viswanath, Ivan Urits

    Published 2022-09-01
    “…# Purpose of Review Attention deficit hyperactivity disorder (ADHD) is a widely diagnosed neurodevelopmental disorder giving rise to symptoms of hyperactivity, impulsivity, and inattentiveness that can impair daily functioning. …”
    Get full text
    Article
  5. 5

    Factors associated with attention-deficit/hyperactivity disorder among Tunisian children by Asma Guedria, Asma Guedria, Asma Guedria, Mohamed Guedria, Manel Ben Fredj, Manel Ben Fredj, Randaline Ayoub, Randaline Ayoub, Randaline Ayoub, Hela Ben Abid, Hela Ben Abid, Hela Ben Abid, Ahmed Mhalla, Ahmed Mhalla, Ahmed Mhalla, Hela Slama, Hela Slama

    Published 2025-02-01
    “…IntroductionAttention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental condition that affects millions of children and adolescents worldwide. …”
    Get full text
    Article
  6. 6

    Investigating behavioural addictions in adults with and without attention deficit hyperactivity disorder. by James L Findon, Annika Muck, Beáta Tóthpál-Davison, Eleanor J Dommett

    Published 2025-01-01
    “…Attention deficit hyperactivity disorder (ADHD) confers greater risk of alcohol and substance use disorders, which may be linked to altered compulsivity and impulsivity within the condition. …”
    Get full text
    Article
  7. 7
  8. 8

    Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation by Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi, Alan D. Kaye

    Published 2023-07-01
    “…The drug has been used to treat depression, Attention Deficit Hyperactivity Disorder (ADHD), and smoking cessation. …”
    Get full text
    Article
  9. 9

    Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany by Nikolaos Kotsopoulos, Mark P. Connolly, Esther Sobanski, Maarten J. Postma

    Published 2013-11-01
    “…**Background:** Attention-deficit hyperactivity disorder (ADHD) is a condition which has been consistently documented to impact educational outcomes. …”
    Get full text
    Article
  10. 10

    Vestibular and balance dysfunction in attention deficit hyperactivity disorder and cognitive disengagement syndrome risk groups by Zuhal Koc Apaydın, Emre Soylemez, Nefise Demir

    Published 2025-02-01
    “…Abstract Background In the past, cognitive disengagement syndrome (CDS) and attention deficit hyperactivity disorder (ADHD) were considered similar concepts. …”
    Get full text
    Article
  11. 11

    Economic Evaluation of a Novel Treatment of Attention-Deficit/Hyperactivity Disorder in US Motor Vehicle Drivers by Jacie T. Cooper, John E. Schneider, Jim Potenziano, David S. Fam

    Published 2024-09-01
    “…**Background:** Attention-deficit/hyperactivity disorder (ADHD) affects approximately 4.4% of US adults. …”
    Get full text
    Article
  12. 12

    Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers by Emuella Flood, Kavita Gajria, Vanja Sikirica, Paul Hodgkins, M. Haim Erder, Frank Lopez, Daniel Connor

    Published 2016-10-01
    “…Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomoxetine (ATX) are two non-stimulant medications approved in the United States for the treatment of ADHD. …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15

    Genome data based deep learning identified new genes predicting pharmacological treatment response of attention deficit hyperactivity disorder by Yilu Zhao, Zhao Fu, Eric J. Barnett, Ning Wang, Kangfuxi Zhang, Xuping Gao, Xiangyu Zheng, Junbin Tian, Hui Zhang, XueTong Ding, Shaoxian Li, Shuyu Li, Qingjiu Cao, Suhua Chang, Yufeng Wang, Stephen V. Faraone, Li Yang

    Published 2025-02-01
    “…Abstract Although the efficacy of pharmacy in the treatment of attention deficit/hyperactivity disorder (ADHD) has been well established, the lack of predictors of treatment response poses great challenges for personalized treatment. …”
    Get full text
    Article
  16. 16

    Exploring correlations between Conners’ Continuous Performance Test and subjective measures of attention deficit hyperactivity disorder symptoms in a paediatric clinical sample by Xue Wei Wendy Poh, Shernice Shi Yun Lim, Ying Yin Chew, Nikki Shi Jie Lim-Ashworth, Choon Guan Lim

    Published 2024-10-01
    “…Introduction: Attention deficit hyperactivity disorder (ADHD) is a childhood-onset neurodevelopmental condition characterised by inattention and/or hyperactivity–impulsivity. …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19
  20. 20